REDUCTION IN SIZE OF PROLACTIN-SECRETING TUMORS IN MEN TREATED WITH PERGOLIDE

被引：29

作者：

KENDALLTAYLOR, P ^{[1
]}

HALL, K ^{[1
]}

JOHNSTON, DG ^{[1
]}

PRESCOTT, RWG ^{[1
]}

机构：

[1] NEWCASTLE GEN HOSP,DEPT NEURORADIOL,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND

来源：

BRITISH MEDICAL JOURNAL | 1982年 / 285卷 / 6340期

关键词：

D O I：

10.1136/bmj.285.6340.465

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：465 / 467

页数：3

共 9 条

[1]

FRANKS S, 1981, LANCET, V2, P659

[2] REGRESSION OF PITUITARY-TUMORS, A POSSIBLE EFFECT OF BROMERGOCRYPTINE [J].

GEORGE, SR ;

BURROW, GN ;

ZINMAN, B ;

EZRIN, C .

AMERICAN JOURNAL OF MEDICINE, 1979, 66 (04) :697-702

[3] INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS [J].

GOLDSTEIN, M ;

LIEBERMAN, A ;

LEW, JY ;

ASANO, T ;

ROSENFELD, MR ;

MAKMAN, MH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3725-3728

[4] 2 NEW DOPAMINE AGONISTS THAT ARE LONG-ACTING INVIVO BUT SHORT-ACTING INVITRO [J].

GROSSMAN, A ;

YEO, T ;

DELITALA, G ;

HATHWAY, NR ;

BESSER, GM .

CLINICAL ENDOCRINOLOGY, 1980, 13 (06) :595-599

[5] PERGOLIDE MESYLATE - A POTENT DAY-LONG INHIBITOR OF PROLACTIN IN RHESUS-MONKEYS AND PATIENTS WITH PARKINSONS-DISEASE [J].

KLEINBERG, DL ;

LIEBERMAN, A ;

TODD, J ;

GREISING, J ;

NEOPHYTIDES, A ;

KUPERSMITH, M .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (01) :152-154

[6] PHARMACOLOGIC EFFECTS IN MAN OF A POTENT, LONG-ACTING DOPAMINE RECEPTOR AGONIST [J].

LEMBERGER, L ;

CRABTREE, RE .

SCIENCE, 1979, 205 (4411) :1151-1153

[7] PERGOLIDE, A POTENT LONG-ACTING DOPAMINE-RECEPTOR AGONIST [J].

LEMBERGER, L ;

CRABTREE, R ;

CALLAGHAN, JT .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) :642-651

[8] EFFECTS OF BROMOCRIPTINE ON PITUITARY-TUMOR SIZE [J].

MCGREGOR, AM ;

SCANLON, MF ;

HALL, R ;

HALL, K .

BRITISH MEDICAL JOURNAL, 1979, 2 (6192) :700-703

[9]

PRESCOTT RWG, 1982, LANCET, V1, P245

← 1 →